語系:
繁體中文
English
說明(常見問題)
圖資館首頁
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Diabetes mellitusa risk factor for A...
~
Nakabeppu, Yusaku.
Diabetes mellitusa risk factor for Alzheimer's disease /
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Diabetes mellitusedited by Yusaku Nakabeppu, Toshiharu Ninomiya.
其他題名:
a risk factor for Alzheimer's disease /
其他作者:
Nakabeppu, Yusaku.
出版者:
Singapore :Springer Singapore :2019.
面頁冊數:
vi, 248 p. :ill., digital ;24 cm.
Contained By:
Springer eBooks
標題:
Diabetes.
電子資源:
https://doi.org/10.1007/978-981-13-3540-2
ISBN:
9789811335402$q(electronic bk.)
Diabetes mellitusa risk factor for Alzheimer's disease /
Diabetes mellitus
a risk factor for Alzheimer's disease /[electronic resource] :edited by Yusaku Nakabeppu, Toshiharu Ninomiya. - Singapore :Springer Singapore :2019. - vi, 248 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,11280065-2598 ;. - Advances in experimental medicine and biology ;946..
Chapter 1 Origins of brain insulin and its function -- Chapter 2 Epidemiological evidence of the relationship between diabetes and dementia -- Chapter 3 Molecular pathophysiology of insulin depletion, mitochondrial dysfunction, and oxidative stress in Alzheimer's Disease Brain -- Chapter 4 The Full Spectrum of Alzheimer's Disease is Rooted in Metabolic -- Derangements That Drive Type 3 Diabetes -- Chapter 5 The roles of apolipoprotein E, lipids and glucose in the pathogenesis of Alzheimer's disease -- Chapter 6 Molecular connection between diabetes and dementia -- Chapter 7 Type II Diabetes mellitus accelerates age-dependent Ab pathology in cynomolgus monkey brain -- Chapter 8 Diabetes-related dementia -- Chapter 9 Tortuous paths of insulin signaling and mitochondria in Alzheimer's disease -- Chapter 10 Mammalian target of rapamycin at the crossroad between Alzheimer's Disease and diabetes -- Chapter 11 Therapeutic strategies for Alzheimer's disease in the view of diabetes mellitus.
This book describes the precise mechanisms by which insulin resistance and diabetes mellitus (DM) act as risk factors for Alzheimer's disease (AD) It opens by discussing the de novo synthesis of insulin in the brain and its functional significance with regard to glucose metabolism and maintenance of neuronal function in the brain. The epidemiological evidence that DM is a risk factor for the development of dementia, including AD as well as vascular dementia, is then examined. Subsequent chapters explore in depth the mechanisms involved in this relationship, including abnormal protein processing, dysregulated glucose metabolism, impaired insulin signaling, and mitochondrial dysfunction. The molecular interactions between diabetes and AD are fully discussed, highlighting the pathological molecular mechanisms induced by diabetes that promote and accelerate AD pathology. Finally, diagnostic biomarkers and potential therapeutic approaches for AD are considered on the basis of the presented evidence. In providing answers to the critical questions of whether and why DM is a risk factor for AD, this book will hold appeal for a wide interdisciplinary audience.
ISBN: 9789811335402$q(electronic bk.)
Standard No.: 10.1007/978-981-13-3540-2doiSubjects--Topical Terms:
274215
Diabetes.
LC Class. No.: RC660 / .D533 2019
Dewey Class. No.: 616.462
Diabetes mellitusa risk factor for Alzheimer's disease /
LDR
:03258nmm a2200337 a 4500
001
558600
003
DE-He213
005
20191016154909.0
006
m d
007
cr nn 008maaau
008
191219s2019 si s 0 eng d
020
$a
9789811335402$q(electronic bk.)
020
$a
9789811335396$q(paper)
024
7
$a
10.1007/978-981-13-3540-2
$2
doi
035
$a
978-981-13-3540-2
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC660
$b
.D533 2019
072
7
$a
PSAN
$2
bicssc
072
7
$a
MED057000
$2
bisacsh
072
7
$a
PSAN
$2
thema
082
0 4
$a
616.462
$2
23
090
$a
RC660
$b
.D536 2019
245
0 0
$a
Diabetes mellitus
$h
[electronic resource] :
$b
a risk factor for Alzheimer's disease /
$c
edited by Yusaku Nakabeppu, Toshiharu Ninomiya.
260
$a
Singapore :
$b
Springer Singapore :
$b
Imprint: Springer,
$c
2019.
300
$a
vi, 248 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
Advances in experimental medicine and biology,
$x
0065-2598 ;
$v
1128
505
0
$a
Chapter 1 Origins of brain insulin and its function -- Chapter 2 Epidemiological evidence of the relationship between diabetes and dementia -- Chapter 3 Molecular pathophysiology of insulin depletion, mitochondrial dysfunction, and oxidative stress in Alzheimer's Disease Brain -- Chapter 4 The Full Spectrum of Alzheimer's Disease is Rooted in Metabolic -- Derangements That Drive Type 3 Diabetes -- Chapter 5 The roles of apolipoprotein E, lipids and glucose in the pathogenesis of Alzheimer's disease -- Chapter 6 Molecular connection between diabetes and dementia -- Chapter 7 Type II Diabetes mellitus accelerates age-dependent Ab pathology in cynomolgus monkey brain -- Chapter 8 Diabetes-related dementia -- Chapter 9 Tortuous paths of insulin signaling and mitochondria in Alzheimer's disease -- Chapter 10 Mammalian target of rapamycin at the crossroad between Alzheimer's Disease and diabetes -- Chapter 11 Therapeutic strategies for Alzheimer's disease in the view of diabetes mellitus.
520
$a
This book describes the precise mechanisms by which insulin resistance and diabetes mellitus (DM) act as risk factors for Alzheimer's disease (AD) It opens by discussing the de novo synthesis of insulin in the brain and its functional significance with regard to glucose metabolism and maintenance of neuronal function in the brain. The epidemiological evidence that DM is a risk factor for the development of dementia, including AD as well as vascular dementia, is then examined. Subsequent chapters explore in depth the mechanisms involved in this relationship, including abnormal protein processing, dysregulated glucose metabolism, impaired insulin signaling, and mitochondrial dysfunction. The molecular interactions between diabetes and AD are fully discussed, highlighting the pathological molecular mechanisms induced by diabetes that promote and accelerate AD pathology. Finally, diagnostic biomarkers and potential therapeutic approaches for AD are considered on the basis of the presented evidence. In providing answers to the critical questions of whether and why DM is a risk factor for AD, this book will hold appeal for a wide interdisciplinary audience.
650
0
$a
Diabetes.
$3
274215
650
0
$a
Alzheimer's disease
$x
Risk factors.
$3
841305
650
1 4
$a
Neurosciences.
$3
211508
650
2 4
$a
Neurology.
$3
211583
700
1
$a
Nakabeppu, Yusaku.
$3
841303
700
1
$a
Ninomiya, Toshiharu.
$3
841304
710
2
$a
SpringerLink (Online service)
$3
273601
773
0
$t
Springer eBooks
830
0
$a
Advances in experimental medicine and biology ;
$v
946.
$3
557559
856
4 0
$u
https://doi.org/10.1007/978-981-13-3540-2
950
$a
Biomedical and Life Sciences (Springer-11642)
筆 0 讀者評論
全部
電子館藏
館藏
1 筆 • 頁數 1 •
1
條碼號
館藏地
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
000000170990
電子館藏
1圖書
電子書
EB RC660 .D536 2019 2019
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
多媒體檔案
https://doi.org/10.1007/978-981-13-3540-2
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入